The_DT LisRK_NP Signal_NP Transduction_NP System_NP Determines_NP the_DT Sensitivity_NN of_IN Listeria_NN monocytogenes_NNS to_TO Nisin_NP and_CC Cephalosporins_NP The_DT Listeria_NN monocytogenes_NNS two-component_JJ signal_NN transduction_NN system_NN ,_, LisRK_NP ,_, initially_RB identified_VBN in_IN strain_NN LO28_NP ,_, plays_VBZ a_DT significant_JJ role_NN in_IN the_DT virulence_NN potential_NN of_IN this_DT important_JJ food-borne_JJ pathogen_NN ._SENT Here_RB ,_, it_PP is_VBZ shown_VBN that_IN ,_, in_IN addition_NN to_TO its_PP$ major_JJ contribution_NN in_IN responding_VBG to_TO ethanol_NN ,_, pH_NN ,_, and_CC hydrogen_NN peroxide_NN stresses_NNS ,_, LisRK_NP is_VBZ involved_VBN in_IN the_DT ability_NN of_IN the_DT cell_NN to_TO tolerate_VB important_JJ antimicrobials_NNS used_VBN in_IN food_NN and_CC in_IN medicine_NN ,_, e.g._FW ,_, the_DT lantibiotic_JJ nisin_NN and_CC the_DT cephalosporin_NN family_NN of_IN antibiotics_NNS ._SENT A_DT DeltalisK_NP mutant_NN (_( lacking_VBG the_DT LisK_NP histidine_NN kinase_NN sensor_NN component_NN )_) displays_VBZ significantly_RB enhanced_JJ resistance_NN to_TO the_DT lantibiotic_JJ nisin_NN ,_, a_DT greatly_RB enhanced_VBN sensitivity_NN to_TO the_DT cephalosporins_NNS ,_, and_CC a_DT large_JJ reduction_NN in_IN the_DT expression_NN of_IN three_CD genes_NNS thought_VBD to_TO encode_VB a_DT penicillin-binding_JJ protein_NN ,_, another_DT histidine_NN kinase_NN (_( other_JJ than_IN LisK_NP )_) ,_, and_CC a_DT protein_NN of_IN unknown_JJ function_NN ._SENT Confirmation_NN of_IN the_DT role_NN of_IN LisRK_NP was_VBD obtained_VBN when_WRB the_DT response_NN regulator_NN ,_, LisR_NP ,_, was_VBD overexpressed_VBN using_VBG both_DT constitutive_JJ and_CC inducible_JJ (_( nisin-controlled_JJ expression_NN )_) systems_NNS ._SENT Under_IN these_DT conditions_NNS we_PP observed_VBD a_DT reversion_NN of_IN the_DT DeltalisK_NP mutant_NN to_TO wild-type_NN growth_NN kinetics_NNS in_IN the_DT presence_NN of_IN nisin_NN ._SENT It_PP was_VBD also_RB found_VBN that_DT overexpression_NN of_IN LisR_NP complemented_VBD the_DT reduced_VBN expression_NN of_IN two_CD of_IN the_DT aforementioned_JJ genes_NNS ._SENT These_DT results_NNS demonstrate_VBP the_DT important_JJ role_NN of_IN LisRK_NP in_IN the_DT response_NN of_IN L._NP monocytogenes_NNS to_TO a_DT number_NN of_IN antimicrobial_JJ agents_NNS ._SENT The_DT gram-positive_JJ pathogen_NN Listeria_NN monocytogenes_NNS imposes_VBZ a_DT significant_JJ burden_NN in_IN terms_NNS of_IN both_DT human_JJ and_CC economic_JJ costs_NNS ._SENT Listeria_NN was_VBD responsible_JJ for_IN 71_CD %_NN of_IN all_DT recalls_NNS of_IN food_NN products_NNS due_JJ to_TO bacterial_JJ contamination_NN in_IN the_DT United_NP States_NPS between_IN 1993_CD and_CC 1998_CD and_CC ,_, more_RBR importantly_RB ,_, is_VBZ the_DT cause_NN of_IN almost_RB 30_CD %_NN of_IN all_DT deaths_NNS caused_VBN by_IN food-borne_JJ pathogens_NNS in_IN the_DT United_NP States_NPS every_DT year_NN ._SENT As_IN a_DT consequence_NN ,_, developing_VBG methodologies_NNS to_TO control_VB the_DT survival_NN and_CC growth_NN of_IN Listeria_NN in_IN foods_NNS and_CC during_IN infection_NN is_VBZ a_DT significant_JJ research_NN goal_NN ._SENT In_IN this_DT respect_NN it_PP is_VBZ vital_JJ that_IN a_DT more_RBR complete_JJ understanding_NN of_IN how_WRB L._NP monocytogenes_NNS responds_VBZ to_TO the_DT presence_NN of_IN those_DT antimicrobial_JJ agents_NNS currently_RB used_VBN to_TO control_VB this_DT pathogen_NN ,_, both_CC ex_JJ vivo_RB (_( e.g._FW ,_, food_NN grade_NN inhibitors_NNS such_JJ as_IN bacteriocins_NNS in_IN foods_NNS )_) and_CC in_IN vivo_RB (_( e.g._FW ,_, antibiotics_NNS )_) ,_, is_VBZ developed_VBN ._SENT This_DT information_NN will_MD be_VB crucial_JJ in_IN reducing_VBG the_DT human_JJ and_CC economic_JJ costs_NNS associated_VBN with_IN Listeria_NN and_CC listeriosis_NN ._SENT Our_PP$ understanding_NN of_IN the_DT mode_NN of_IN action_NN of_IN nisin_NN ,_, the_DT only_JJ lantibiotic_NN approved_VBN by_IN the_DT U.S._NP Food_NP and_CC Drug_NP Administration_NP for_IN use_NN as_IN a_DT food_NN grade_NN inhibitor_NN ,_, is_VBZ increasing_VBG ._SENT It_PP is_VBZ now_RB known_VBN that_IN nisin_NN functions_NNS ,_, at_IN least_JJS in_IN part_NN ,_, by_IN the_DT formation_NN of_IN pores_NNS in_IN the_DT bacterial_JJ cell_NN membrane_NN ,_, with_IN the_DT interaction_NN being_VBG largely_RB dependent_JJ on_IN the_DT type_NN of_IN lipids_NNS present_JJ and_CC ,_, most_RBS importantly_RB ,_, the_DT charge_NN carried_VBN by_IN those_DT lipids_NNS ._SENT Pore_NN formation_NN is_VBZ facilitated_VBN by_IN the_DT binding_NN of_IN nisin_NN to_TO lipid_NN II_NP ,_, a_DT membrane-bound_JJ peptidoglycan_NN precursor_NN ,_, which_WDT is_VBZ thought_VBN to_TO function_VB as_IN a_DT docking_VBG molecule_NN rather_RB than_IN as_IN a_DT receptor_NN ._SENT In_IN addition_NN ,_, the_DT binding_NN of_IN nisin_NN to_TO lipid_NN II_NP is_VBZ responsible_JJ for_IN a_DT secondary_JJ mode_NN of_IN action_NN ,_, i.e._FW ,_, inhibition_NN of_IN cell_NN wall_NN synthesis_NN ._SENT Thus_RB nisin_NN inhibits_VBZ bacterial_JJ growth_NN by_IN a_DT combination_NN of_IN these_DT two_CD mechanisms_NNS ._SENT Despite_IN the_DT extent_NN of_IN this_DT knowledge_NN the_DT role_NN of_IN host_NN genes_NNS in_IN determining_VBG nisin_NN sensitivity_NN and_CC resistance_NN is_VBZ less_RBR clear_JJ ._SENT In_IN vivo_RB ,_, i.e._FW ,_, in_IN infection_NN by_IN Listeria_NN ,_, ampicillin_NN ,_, alone_RB or_CC in_IN combination_NN with_IN gentamicin_NN ,_, remains_VBZ the_DT treatment_NN of_IN choice_NN ._SENT However_RB ,_, the_DT high_JJ level_NN of_IN innate_JJ resistance_NN to_TO cephalosporin_NN antibiotics_NNS that_IN Listeria_NN possesses_VBZ may_MD be_VB especially_RB significant_JJ as_IN members_NNS of_IN this_DT family_NN of_IN drugs_NNS are_VBP used_VBN most_RBS frequently_RB for_IN sepsis_NN due_JJ to_TO unknown_JJ causes_NNS ._SENT While_IN cephalosporins_NNS were_VBD found_VBN to_TO be_VB efficient_JJ inhibitors_NNS of_IN penicillin-binding_VBG protein_NN 1_CD (_( PBP1_NP )_) ,_, -2_CD ,_, and_CC -4_CD in_IN L._NP monocytogenes_NNS ,_, which_WDT are_VBP completely_RB blocked_VBN at_IN concentrations_NNS well_RB below_IN the_DT MIC_NP ,_, the_DT innate_JJ resistance_NN to_TO cephalosporins_NNS is_VBZ thought_VBN to_TO be_VB due_JJ to_TO their_PP$ lack_NN of_IN affinity_NN for_IN PBP3_NP ,_, the_DT primary_JJ lethal_JJ target_NN for_IN beta-lactams_NNS in_IN the_DT species_NN ._SENT Here_RB we_PP report_VBP that_IN LisRK_NP ,_, an_DT L._NP monocytogenes_NNS two-component_JJ signal_NN transduction_NN system_NN which_WDT we_PP previously_RB identified_VBD and_CC which_WDT has_VBZ been_VBN found_VBN to_TO play_VB a_DT role_NN in_IN acid_NN ,_, ethanol_NN ,_, and_CC oxidative_JJ stress_NN and_CC in_IN murine_JJ virulence_NN ,_, also_RB plays_VBZ a_DT major_JJ role_NN in_IN the_DT retardation_NN of_IN the_DT growth_NN of_IN Listeria_NN in_IN the_DT presence_NN of_IN nisin_NN and_CC in_IN the_DT innate_JJ cephalosporin_NN resistance_NN of_IN this_DT pathogen_NN ._SENT In_IN addition_NN ,_, for_IN the_DT first_JJ time_NN ,_, genes_NNS regulated_VBN by_IN LisRK_NP have_VBP been_VBN identified_VBN ._SENT It_PP was_VBD found_VBN that_DT overexpression_NN of_IN the_DT gene_NN encoding_VBG the_DT response_NN regulator_NN component_NN of_IN the_DT system_NN ,_, lisR_NN ,_, could_MD complement_VB a_DT number_NN of_IN the_DT phenotypic_JJ consequences_NNS of_IN mutating_VBG lisK_NN (_( the_DT gene_NN encoding_VBG the_DT histidine_NN kinase_NN component_NN )_) as_RB well_RB as_IN restoring_VBG expression_NN of_IN two_CD of_IN the_DT three_CD regulated_JJ genes_NNS ._SENT Strains_NNS ,_, plasmids_NNS and_CC media_NNS ._SENT |_SYM L._NP monocytogenes_NNS LO28_NP (_( serotype_NP 1/2c_NP )_) is_VBZ a_DT clinical_JJ isolate_NN obtained_VBN from_IN P._NP Cossart_NP ,_, Institut_NP Pasteur_NP ,_, Paris_NP ,_, France_NP ._SENT LO28DeltalisK_NP is_VBZ a_DT mutant_NN from_IN which_WDT a_DT portion_NN of_IN the_DT histidine_NN kinase-encoding_NN gene_NN ,_, lisK_NN ,_, has_VBZ been_VBN deleted_VBN by_IN splicing_VBG by_IN overlap_VBP extension_NN (_( SOEing_NP )_) PCR_NP ._SENT The_DT culture_NN medium_NN used_VBN was_VBD tryptone_JJ soy_NN agar_NN or_CC tryptone_NN soy_NN broth_NN (_( Oxoid_NP ,_, Basingstoke_NP ,_, Hampshire_NP ,_, England_NP )_) supplemented_VBD with_IN 0.6_CD %_NN yeast_NN extract_NN (_( Difco_NP )_) (_( TSA-YE_NP or_CC TSB-YE_NP )_) or_CC brain_NN heart_NN infusion_NN (_( BHI_NP )_) agar_NN or_CC broth_NN (_( Oxoid_NP )_) ._SENT Plasmid_NP pKSV7_JJ ,_, used_VBN for_IN SOEing_NP PCR_NP ,_, was_VBD a_DT kind_NN gift_NN from_IN Kathryn_NP Boor_NP ,_, Cornell_NP University_NP ,_, Ithaca_NP ,_, N.Y._NP Plasmids_NP pNZ8048_NN and_CC pNZ9530_NN were_VBD gifts_NNS from_IN Michiel_NP Kleerebezem_NP ,_, NIZO_NP ,_, Ede_NP ,_, The_DT Netherlands_NPS ._SENT Plasmid_NP pNZ44_NP was_VBD a_DT gift_NN from_IN Stephen_NP McGrath_NP ,_, University_NP College_NP Cork_NP ,_, Cork_NP ,_, Ireland_NP ._SENT Growth_NN in_IN the_DT presence_NN of_IN nisin_NN ._SENT |_SYM The_DT rates_NNS of_IN growth_NN of_IN L._NP monocytogenes_NNS LO28_NP and_CC LO28DeltalisK_NP in_IN the_DT presence_NN of_IN different_JJ levels_NNS of_IN nisin_NN (_( 2_CD %_NN inoculum_NN in_IN TSB-YE_NP containing_VBG 50_CD ,_, 100_CD ,_, 150_CD ,_, 200_CD ,_, or_CC 300_CD mug_NN of_IN nisin_JJ powder_NN [_SYM Sigma_NP ,_, St._NP Louis_NP ,_, Mo.]/ml_NP )_) were_VBD compared_VBN by_IN monitoring_VBG optical_JJ density_NN at_IN 600_CD nm_NN (_( OD600_NP )_) with_IN a_DT Spectra_NP Max_NP 340_CD spectrophotometer_NN (_( Molecular_NP Devices_NP ,_, Sunnyvale_NP ,_, Calif._NP )_) over_IN a_DT 20-h_JJ period_NN ._SENT Antibiotic_JJ assays_NNS ._SENT |_SYM Assays_NP to_TO determine_VB the_DT sensitivities_NNS of_IN LO28_NP and_CC LO28DeltalisK_NP to_TO a_DT wide_JJ range_NN of_IN antibiotics_NNS were_VBD carried_VBN out_RP by_IN agar_NN diffusion_NN ._SENT Overnight_JJ cultures_NNS were_VBD diluted_VBN to_TO 106_CD CFU/ml_NN and_CC swabbed_VBN onto_IN TSA-YE_NP ._SENT Commercially_RB purchased_VBN disks_NNS (_( 6_CD mm_NN in_IN diameter_NN ;_: Oxoid_NP )_) containing_VBG 30_CD mug_NN (_( unless_IN otherwise_RB stated_VBN )_) of_IN the_DT antibiotics_NNS to_TO be_VB studied_VBN were_VBD then_RB placed_VBN on_IN the_DT surfaces_NNS of_IN agar_NN plates_NNS ._SENT Following_VBG overnight_JJ incubation_NN of_IN the_DT plates_NNS at_IN 37C_JJ ,_, the_DT diameters_NNS of_IN the_DT zones_NNS of_IN bacterial_JJ growth_NN inhibition_NN surrounding_VBG the_DT filter_NN disks_NNS were_VBD measured_VBN ._SENT The_DT relative_JJ susceptibilities_NNS of_IN different_JJ strains_NNS to_TO the_DT various_JJ antibiotics_NNS tested_VBN were_VBD correlated_VBN with_IN the_DT sizes_NNS of_IN the_DT zones_NNS of_IN inhibition_NN ,_, with_IN increased_VBN zone_NN size_NN reflecting_VBG increased_VBN susceptibility_NN ._SENT Initially_RB the_DT antibiotics_NNS assayed_VBN were_VBD cefotaxime_JJ ,_, cefuroxime_NN ,_, vancomycin_NP ,_, erythromycin_NN ,_, kanamycin_NN ,_, fosfomycin_NN (_( 50_CD mug_NN )_) ,_, minocycline_NN ,_, polymyxin_NN B_NP (_( 300_CD mug_NN )_) ,_, streptomycin_NN (_( 25_CD mug_NN )_) ,_, fusidic_JJ acid_NN (_( 10_CD mug_NN )_) ,_, oxytetracycline_NN ,_, penicillin_NN (_( 10_CD mug_NN )_) ,_, clindamycin_NN (_( 10_CD mug_NN )_) ,_, spectinomycin_NN (_( 25_CD mug_NN )_) ,_, ampicillin_NN (_( 25_CD mug_NN )_) ,_, novobiocin_NP ,_, rifampin_NN ,_, nalidixic_JJ acid_NN ,_, gentamicin_NN ,_, colistin_NN sulfate_NN (_( 25_CD mug_NN )_) ,_, chloramphenicol_NN (_( CAM_NP )_) ,_, and_CC tetracycline_NN ._SENT In_IN addition_NN to_TO this_DT assay_NN ,_, designed_VBN to_TO compare_VB antibiotic_JJ susceptibilities_NNS in_IN general_JJ ,_, further_JJR studies_NNS involved_VBD disks_NNS containing_VBG antibiotics_NNS of_IN the_DT cephalosporin_NN family_NN ._SENT These_DT were_VBD cefuroxime_JJ ,_, ceftazidime_NN ,_, cefaclor_NN ,_, cephalothin_NN ,_, cefoxitin_NN ,_, ceftriaxone_NN ,_, cefotetan_NP ,_, cefoperazone_NN ,_, cephradine_NN ,_, cephalexin_NN ,_, and_CC cefotaxime_NN (_( all_DT 30_CD mug_NN )_) ._SENT Implementation_NN of_IN the_DT nisin-controlled_JJ expression_NN (_( NICE_NP )_) system_NN in_IN L._NP monocytogenes_NNS LO28DeltalisK_NP ._SENT |_SYM A_DT strategy_NN to_TO replace_VB the_DT hemolysin_NN gene_NN ,_, hly_NNS ,_, on_IN the_DT L._NP monocytogenes_NNS chromosome_NN with_IN the_DT nisRK_NN genes_NNS was_VBD devised_VBN ._SENT Primers_NNS were_VBD designed_VBN to_TO amplify_VB the_DT chromosomal_JJ regions_NNS flanking_VBG the_DT hly_NN gene_NN (_( primers_NNS HSOEA_NN ,_, -B_NN ,_, -C_NN ,_, and_CC -D_NNS ;_: Table_NP )_) ._SENT The_DT resultant_JJ A-B_NN and_CC C-D_JJ fragments_NNS were_VBD spliced_VBN by_IN overlap_VB extension_NN PCR_NP using_VBG primers_NNS HSOEA_NN and_CC -D_NN to_TO create_VB a_DT single_JJ A-D_NN fragment_NN ,_, representing_VBG the_DT region_NN surrounding_VBG hly_NNS but_CC with_IN the_DT gene_NN precisely_RB removed_VBN ._SENT This_DT fragment_NN was_VBD subsequently_RB cloned_VBN in_IN temperature-sensitive_NN plasmid_NN pKSV7_JJ ._SENT Since_IN primers_NNS B_NP and_CC C_NP have_VBP built-in_JJ restriction_NN sites_NNS ,_, we_PP were_VBD able_JJ to_TO clone_NN the_DT nisRK_NN operon_NN (_( amplified_VBN ,_, by_IN using_VBG primers_NNS nisRF_NN and_CC nisKB_NN ,_, from_IN pNZ9530_NN )_) into_IN the_DT location_NN formerly_RB occupied_VBN by_IN hly_NNS ._SENT This_DT plasmid_NP construct_NN ,_, pCPL-53_NN ,_, was_VBD electroporated_VBN into_IN L._NP monocytogenes_NNS LO28DeltalisK_NP ,_, and_CC transformants_NNS were_VBD selected_VBN on_IN BHI_NP agar_NN with_IN 10_CD mug_NN of_IN CAM/ml_NP (_( BHI/CAM_NP )_) ._SENT Chromosomal_JJ integration_NN of_IN the_DT plasmid_NN at_IN 41C_NP was_VBD selected_VBN by_IN serial_JJ passage_NN of_IN a_DT transformant_NN in_IN prewarmed_JJ BHI/CAM_NP broth_NN and_CC streaking_VBG onto_IN prewarmed_JJ BHI/CAM_NP agar_NN ._SENT Plasmid_NP excision_NN was_VBD accomplished_VBN by_IN continuous_JJ passage_NN in_IN BHI_NP at_IN 30C_JJ ,_, and_CC clones_NNS in_IN which_WDT nisRK_NN had_VBD replaced_VBN hly_NNS on_IN the_DT chromosome_NN were_VBD identified_VBN by_IN plating_VBG them_PP onto_IN blood_NN agar_NN plates_NNS at_IN 30C_JJ ._SENT Replica_NN plating_NN of_IN nonhemolytic_JJ colonies_NNS onto_IN BHI_NP and_CC BHI/CAM_NP at_IN 30C_NP identified_VBD cured_VBN derivatives_NNS ._SENT PCR_NP and_CC sequencing_VBG analysis_NN of_IN one_CD such_JJ strain_NN confirmed_VBD that_IN the_DT nisRK_NN operon_NN had_VBD replaced_VBN the_DT hly_JJ gene_NN ._SENT This_DT strain_NN was_VBD designated_VBN LO28DeltalisK-NICE_NP ._SENT Overexpression_NN of_IN lisR_NN ._SENT |_SYM PCR_NP primers_NNS NZlisRF_NP (_( containing_VBG the_DT lisR_NN start_NN codon_NN )_) and_CC NZlisRB_NP (_( containing_VBG the_DT lisR_NN stop_NN codon_NN )_) with_IN incorporated_JJ NcoI_NP and_CC XbaI_NP sites_NNS ,_, respectively_RB ,_, were_VBD used_VBN to_TO amplify_VB lisR_NN from_IN LO28_NP ._SENT The_DT resultant_JJ PCR_NP product_NN was_VBD digested_VBN with_IN NcoI_NP and_CC XbaI_NP restriction_NN enzymes_NNS (_( Roche_NP )_) and_CC cloned_VBN into_IN similarly_RB digested_VBN pNZ8048_NN ,_, resulting_VBG in_IN the_DT generation_NN of_IN a_DT translational_JJ fusion_NN between_IN the_DT nisin-inducible_JJ nisA_NN promoter_NN on_IN pNZ8048_NN and_CC the_DT lisR_NN gene_NN ._SENT This_DT event_NN was_VBD confirmed_VBN by_IN sequence_NN analysis_NN ._SENT This_DT strain_NN was_VBD designated_VBN LO28DeltalisK-NICE(pNZ8048-lisR_NP )_) ._SENT pNZ8048_NN was_VBD also_RB introduced_VBN into_IN the_DT LO28DeltalisK-NICE_NP background_NN to_TO create_VB LO28DeltalisK-NICE(pNZ8048_NP )_) ._SENT As_IN an_DT alternative_NN to_TO inducible_JJ overexpression_NN ,_, lisR_NN (_( amplified_VBN by_IN primer_NN pair_NN NZlisRF_NP and_CC NZlisRB_NP )_) was_VBD also_RB cloned_VBN into_IN plasmid_NP pNZ44_NP ,_, a_DT derivative_NN of_IN pNZ8048_NN in_IN which_WDT the_DT Pnis_NP promoter_NN was_VBD replaced_VBN by_IN a_DT constitutive_JJ P44_NP promoter_NN ,_, resulting_VBG in_IN the_DT creation_NN of_IN LO28DeltalisK(pNZ44-lisR_NP )_) ._SENT LO28DeltalisK(pNZ44)_NP was_VBD also_RB created_VBN to_TO serve_VB as_IN a_DT control_NN for_IN subsequent_JJ experiments_NNS ._SENT RT-PCR_NP ._SENT |_SYM RNA_NP isolation_NN and_CC reverse_JJ transcription-PCR_NN (_( RT-PCR_NP )_) were_VBD carried_VBN out_RP as_RB described_VBN previously_RB ._SENT RNA_NP was_VBD isolated_VBN from_IN overnight_JJ cultures_NNS (_( constitutive_JJ overexpression_NN system_NN )_) or_CC following_VBG nisin_NN induction_NN (_( inducible_JJ overexpression_NN system_NN )_) ._SENT For_IN induction_NN with_IN nisin_NN cultures_NNS were_VBD grown_VBN to_TO an_DT OD600_NP of_IN 0.2_CD and_CC preinduced_VBN with_IN 4.5_CD mug_NN of_IN nisin_NN powder/ml_NN for_IN 1_CD h_NN ,_, followed_VBN by_IN induction_NN with_IN 45_CD mug_NN of_IN nisin_NN powder/ml_NN (_( a_DT concentration_NN at_IN which_WDT there_EX is_VBZ no_DT difference_NN in_IN the_DT nisin_NN sensitivities_NNS of_IN the_DT two_CD strains_NNS )_) for_IN 30_CD min_NN and_CC then_RB isolation_NN of_IN RNA_NP ._SENT In_IN all_DT cases_NNS cDNA_NN was_VBD amplified_VBN by_IN PCR_NP with_IN specific_JJ primers_NNS and_CC samples_NNS were_VBD taken_VBN at_IN regular_JJ intervals_NNS and_CC run_VBN on_IN agarose_JJ gels_NNS ._SENT Primers_NNS for_IN the_DT 16S_JJ rRNA_NN of_IN L._NP monocytogenes_NNS LO28_NP were_VBD used_VBN as_IN controls_NNS ._SENT TABLE_NN 1_CD |_SYM PCR_NP primers_NNS used_VBN in_IN this_DT study_NN ._SENT Nisin_NN resistance_NN of_IN the_DT DeltalisK_NP mutant_NN ._SENT |_SYM Because_IN deletion_NN of_IN the_DT L._NP monocytogenes_NNS histidine_NN kinase-encoding_NN gene_NN ,_, lisK_NN ,_, results_NNS in_IN an_DT altered_JJ response_NN to_TO environmental_JJ parameters_NNS ,_, we_PP examined_VBD the_DT susceptibility_NN of_IN L._NP monocytogenes_NNS to_TO the_DT lantibiotic_JJ nisin_NN ._SENT It_PP was_VBD found_VBN that_IN the_DT levels_NNS of_IN nisin_NN required_VBN to_TO inhibit_VB growth_NN of_IN wild-type_NP LO28_NP are_VBP high_RB relative_JJ to_TO those_DT required_VBN to_TO inhibit_VB the_DT growth_NN of_IN a_DT number_NN of_IN other_JJ gram-positive_JJ bacteria_NNS ._SENT This_DT is_VBZ a_DT feature_NN of_IN this_DT strain_NN which_WDT we_PP have_VBP previously_RB observed_VBN in_IN relation_NN to_TO other_JJ bacteriocins_NNS such_JJ as_IN lacticin_NP 3147_CD and_CC enterocin_NP A_NP (_( our_PP$ unpublished_JJ data_NNS )_) ._SENT Growth_NN curves_NNS were_VBD carried_VBN out_RP to_TO determine_VB whether_IN deletion_NN of_IN lisK_NN affected_VBD the_DT response_NN to_TO nisin_NN ._SENT In_IN the_DT absence_NN of_IN nisin_NN the_DT growth_NN rates_NNS of_IN the_DT parent_NN and_CC mutant_JJ strains_NNS were_VBD identical_JJ ,_, but_CC in_IN the_DT presence_NN of_IN increasing_VBG levels_NNS of_IN nisin_NN differences_NNS became_VBD apparent_JJ ,_, primarily_RB manifested_VBN as_IN a_DT significantly_RB longer_RBR lag_VB phase_NN in_IN wild-type_NP LO28_NP ._SENT This_DT is_VBZ most_RBS obvious_JJ when_WRB one_PP observes_VBZ that_IN the_DT lag_NN period_NN for_IN LO28_NP in_IN the_DT presence_NN of_IN 300_CD mug_NN of_IN nisin/ml_NN is_VBZ 6_CD h_NN longer_JJR than_IN that_DT for_IN LO28DeltalisK_NP ._SENT There_EX is_VBZ no_DT difference_NN in_IN the_DT growth_NN rates_NNS once_IN the_DT lag_NN phase_NN has_VBZ been_VBN exited_VBN (_( e.g._FW ,_, both_CC are_VBP 0.046_CD U/h_NN during_IN logarithmic_JJ growth_NN in_IN the_DT presence_NN of_IN 200_CD mug_NN of_IN nisin/ml_NN )_) ._SENT Therefore_RB ,_, the_DT LisK_NP mutation_NN results_NNS in_IN a_DT culture_NN that_WDT is_VBZ able_JJ to_TO rapidly_RB initiate_VB growth_NN in_IN the_DT presence_NN of_IN nisin_NN ,_, whereas_IN the_DT parent_NN apparently_RB needs_VBZ a_DT significant_JJ period_NN in_IN which_WDT to_TO adapt_VB to_TO the_DT presence_NN of_IN the_DT inhibitor_NN ._SENT We_PP speculate_VBP that_IN ,_, during_IN prior_JJ growth_NN in_IN the_DT absence_NN of_IN nisin_NN ,_, the_DT LisRK_NP system_NN plays_VBZ a_DT role_NN in_IN creating_VBG a_DT particular_JJ cell_NN envelope_NN composition_NN that_WDT renders_VBZ the_DT cell_NN more_RBR susceptible_JJ to_TO nisin_NNS (_( and_CC also_RB alters_VBZ its_PP$ response_NN to_TO ethanol_NN ,_, low_JJ pH_NN ,_, and_CC hydrogen_NN peroxide_NN [_SYM ,_, ]_SYM )_) ._SENT In_IN the_DT absence_NN of_IN LisK_NP ,_, the_DT cell_NN must_MD presumably_RB fail_VB to_TO sense_VB an_DT as_RB yet_RB unknown_JJ environmental_JJ parameter_NN ,_, resulting_VBG in_IN an_DT altered_JJ envelope_NN composition_NN that_WDT is_VBZ manifested_VBN as_IN rapidly_RB initiated_VBN growth_NN in_IN the_DT nisin_NN assay_NN ._SENT Antibiotic_JJ disk_NN assays_NNS ._SENT |_SYM Antibiotic_JJ disks_NNS were_VBD used_VBN to_TO determine_VB if_IN LO28_NP and_CC LO28DeltalisK_NP differed_VBD in_IN their_PP$ responses_NNS to_TO other_JJ antimicrobial_JJ agents_NNS ._SENT An_DT initial_JJ extensive_JJ study_NN using_VBG a_DT wide_JJ range_NN of_IN antibiotics_NNS (_( see_VB Materials_NNS and_CC Methods_NNS )_) revealed_VBD that_IN only_JJ cefotaxime_NN and_CC cefuroxime_NN differentiated_VBD significantly_RB between_IN the_DT two_CD strains_NNS though_IN a_DT slightly_RB enhanced_JJ (_( though_RB not_RB statistically_RB significant_JJ )_) sensitivity_NN to_TO ampicillin_NN and_CC penicillin_NN was_VBD also_RB observed_VBN ._SENT It_PP was_VBD found_VBN that_IN for_IN the_DT parent_NN strain_NN ,_, LO28_NP ,_, the_DT diameters_NNS of_IN the_DT zones_NNS surrounding_VBG the_DT cefotaxime_NN and_CC cefuroxime_NN disks_NNS were_VBD very_RB small_JJ (_( 16_CD and_CC 15.4_CD mm_NN ,_, respectively_RB )_) ._SENT In_IN contrast_NN ,_, for_IN LO28DeltalisK_NP the_DT diameters_NNS extended_VBD to_TO 26_CD and_CC 26.4_CD mm_NN ,_, representing_VBG significant_JJ 63_CD and_CC 71_CD %_NN increases_NNS in_IN zone_NN size_NN for_IN cefotaxime_NN and_CC cefuroxime_NN ,_, respectively_RB ._SENT As_IN a_DT consequence_NN of_IN the_DT dramatic_JJ nature_NN of_IN these_DT findings_NNS ,_, further_JJR antibiotic_JJ disk_NN assays_NNS were_VBD performed_VBN using_VBG other_JJ antibiotics_NNS of_IN the_DT cephalosporin_NN family_NN ._SENT While_IN ,_, as_IN expected_VBN ,_, it_PP was_VBD observed_VBN that_IN the_DT LO28_NP background_NN was_VBD ,_, in_IN general_JJ ,_, more_RBR sensitive_JJ to_TO narrow-spectrum_NN cephalosporins_NNS (_( e.g._FW ,_, cephalothin_NN ,_, cefaclor_NN ,_, and_CC cephradine_NN )_) ,_, the_DT most_RBS significant_JJ discovery_NN was_VBD the_DT greatly_RB enhanced_VBN sensitivity_NN of_IN the_DT LO28DeltalisK_NP mutant_NN in_IN all_DT cases_NNS ._SENT Our_PP$ observations_NNS are_VBP especially_RB significant_JJ when_WRB one_PP considers_VBZ that_IN ,_, despite_IN L._NP monocytogenes_NNS susceptibility_NN to_TO a_DT wide_JJ range_NN of_IN antibiotics_NNS ,_, it_PP is_VBZ resistant_JJ to_TO the_DT cephalosporins_NNS ,_, a_DT large_JJ and_CC expanding_VBG family_NN of_IN drugs_NNS based_VBN on_IN cephalosporin_NN C_NP which_WDT are_VBP frequently_RB the_DT initial_JJ choice_NN for_IN hospital_NN treatment_NN of_IN bacterial_JJ infection_NN resulting_VBG in_IN fever_NN due_JJ to_TO unidentified_JJ organisms_NNS ._SENT LisRK-regulated_JJ genes_NNS ._SENT |_SYM While_IN the_DT physiological_JJ changes_NNS present_JJ in_IN nisin-resistant_JJ mutants_NNS have_VBP been_VBN examined_VBN on_IN a_DT number_NN of_IN occasions_NNS ,_, until_IN the_DT recent_JJ study_NN by_IN Gravesen_NP et_FW al._FW it_PP was_VBD not_RB known_VBN which_WDT genes_NNS might_MD be_VB involved_VBN ._SENT In_IN a_DT high_JJ percentage_NN of_IN spontaneous_JJ nisin-resistant_JJ L._NP monocytogenes_NNS 412_CD mutants_NNS studied_VBN by_IN this_DT group_NN increases_VBZ in_IN the_DT levels_NNS of_IN cDNA_NN corresponding_JJ to_TO three_CD genes_NNS were_VBD uncovered_VBN by_IN restriction_NN fragment_NN differential-display_NN PCR_NP ._SENT Of_IN the_DT putative_JJ proteins_NNS encoded_VBN by_IN these_DT genes_NNS one_PP showed_VBD high_JJ homology_NN to_TO the_DT glycosyltransferase_NN domains_NNS of_IN PBPs_NP ,_, another_DT was_VBD a_DT histidine_NN kinase_NN (_( though_RB not_RB LisK_NP )_) ,_, and_CC the_DT third_JJ was_VBD a_DT protein_NN of_IN unknown_JJ function_NN ._SENT These_DT findings_NNS were_VBD especially_RB relevant_JJ as_IN a_DT large_JJ proportion_NN of_IN these_DT spontaneous_JJ mutants_NNS also_RB demonstrated_VBD enhanced_JJ resistance_NN to_TO cefuroxime_NN ,_, leading_VBG us_PP to_TO speculate_VB that_IN LisRK_NP may_MD regulate_VB one_CD or_CC more_JJR of_IN the_DT same_JJ genes_NNS ._SENT To_TO determine_VB if_IN this_DT was_VBD the_DT case_NN ,_, RT-PCR_NP analysis_NN was_VBD carried_VBN out_RP to_TO investigate_VB whether_IN transcription_NN of_IN these_DT genes_NNS varies_VBZ between_IN LO28_NP and_CC LO28DeltalisK_NP ._SENT Significantly_RB ,_, it_PP was_VBD found_VBN in_IN all_DT cases_NNS that_IN the_DT relative_JJ level_NN of_IN expression_NN of_IN these_DT three_CD genes_NNS was_VBD greatly_RB reduced_VBN or_CC eliminated_VBN in_IN LO28DeltalisK_NP ._SENT The_DT gene_NN encoding_VBG the_DT putative_JJ PBP_NN in_IN strain_NN 412_CD corresponds_VBZ to_TO the_DT open_JJ reading_NN frame_NN designated_VBN lmo2229_NN in_IN genome-sequenced_JJ strain_NN L._NP monocytogenes_NNS EGD-e_NN ._SENT This_DT putative_JJ PBP_NN shows_VBZ highest_JJS homology_NN to_TO PBP2a_NP of_IN Streptococcus_NP pneumoniae_NP and_CC PBP1a_NP of_IN Bacillus_NN subtilis_NNS ,_, both_CC of_IN which_WDT are_VBP high-molecular-weight_JJ PBPs_NNS possessing_VBG both_DT glycosyltransferase_NN and_CC transpeptidase_NN domains_NNS ._SENT The_DT gene_NN encoding_VBG the_DT histidine_NN kinase_NN corresponds_VBZ to_TO lmo1021_JJ and_CC shows_VBZ homology_NN with_IN the_DT yvqE_JJ gene_NN of_IN B._NP subtilis_NNS and_CC llkinD_NN of_IN Lactococcus_NP lactis_NN (_( genes_NNS encoding_VBG members_NNS of_IN the_DT NarQ/NarX_NP subfamily_NN )_) ._SENT In_IN each_DT case_NN the_DT gene_NN encoding_VBG the_DT histidine_NN kinase_NN is_VBZ located_VBN between_IN a_DT response_NN regulator_NN gene_NN homolog_NN (_( lmo1022_NP ,_, yvqC_NN ,_, or_CC llrrD_NN )_) and_CC a_DT gene_NN encoding_VBG a_DT protein_NN of_IN unknown_JJ function_NN (_( lmo1020_NP ,_, yvqF_NN ,_, or_CC tcdsorf1_JJ )_) ._SENT While_IN mutation_NN of_IN llkinD_NN has_VBZ not_RB been_VBN achieved_VBN ,_, it_PP was_VBD found_VBN that_IN the_DT most_RBS significant_JJ trait_NN associated_VBN with_IN an_DT llrrD_NN mutant_NN was_VBD an_DT increased_VBN osmosensitivity_NN ._SENT However_RB ,_, unlike_IN lisK_NN mutants_NNS ,_, this_DT mutant_NN did_VBD not_RB exhibit_VB enhanced_JJ sensitivity_NN to_TO oxidative_JJ stress_NN ._SENT The_DT third_JJ gene_NN fragment_NN ,_, originally_RB designated_VBN fragment_NN C_NP ,_, corresponds_VBZ to_TO lmo2487_JJ and_CC is_VBZ homologous_JJ to_TO B._NP subtilis_NNS yvlB_NN ,_, the_DT predicted_VBN protein_NN of_IN which_WDT has_VBZ not_RB been_VBN assigned_VBN a_DT function_NN ._SENT While_IN we_PP have_VBP yet_RB to_TO ascertain_VB what_WP role_NN ,_, if_IN any_DT ,_, these_DT three_CD genes_NNS play_VBP in_IN the_DT phenotypes_NNS associated_VBN with_IN the_DT lisK_NN mutation_NN ,_, the_DT variations_NNS in_IN the_DT levels_NNS of_IN transcript_NN and_CC the_DT observation_NN that_IN at_IN least_JJS one_CD other_JJ histidine_NN kinase_NN plays_VBZ a_DT role_NN suggest_VBP that_IN LisRK_NP is_VBZ involved_VBN in_IN a_DT complex_JJ regulatory_JJ pathway_NN ._SENT The_DT apparent_JJ inconsistency_NN between_IN our_PP$ findings_NNS and_CC those_DT of_IN Gravesen_NP et_FW al._FW with_IN regard_NN to_TO the_DT relative_JJ increase_NN or_CC decrease_NN in_IN transcription_NN of_IN these_DT genes_NNS may_MD reflect_VB the_DT growth_NN phases_NNS during_IN which_WDT cells_NNS were_VBD studied_VBN ,_, i.e._FW ,_, late_JJ exponential_JJ phase_NN (_( OD600_NP =_SYM 0.6_CD )_) and_CC late_JJ stationary_JJ phase_NN (_( overnight_JJ growth_NN )_) ,_, respectively_RB ._SENT Growth_NN phase-dependent_NN variations_NNS have_VBP previously_RB been_VBN reported_VBN with_IN respect_NN to_TO the_DT acid_JJ resistance_NN of_IN the_DT LO28DeltalisK_NP mutant_NN ._SENT We_PP can_MD ,_, however_RB ,_, definitively_RB state_NN that_IN alterations_NNS in_IN the_DT levels_NNS of_IN these_DT proteins_NNS are_VBP associated_VBN with_IN nisin_NN resistance_NN and_CC cephalosporin_NN sensitivity_NN ._SENT In_IN addition_NN to_TO this_DT now-established_JJ link_NN between_IN nisin_NN resistance_NN and_CC cephalosporin_NN sensitivity_NN it_PP has_VBZ also_RB been_VBN found_VBN that_IN a_DT number_NN of_IN spontaneous_JJ L._NP innocua_NN 4202_CD mutants_NNS resistant_JJ to_TO bacteriocin_NP AS-48_NP displayed_VBD enhanced_JJ sensitivity_NN to_TO cephradine_NN while_IN lacticin_NN 3147-resistant_JJ L._NP monocytogenes_NNS LO28_NP mutants_NNS were_VBD more_RBR sensitive_JJ to_TO cephalexin_NN ,_, cefaclor_NN ,_, and_CC cephradine_NN ._SENT The_DT recurring_VBG link_NN between_IN bacteriocin_NN resistance_NN and_CC cephalosporin_NN sensitivity_NN is_VBZ thus_RB significant_JJ and_CC merits_NNS further_JJR study_NN ._SENT Intriguing_JJ are_VBP suggestions_NNS that_IN the_DT S._NP pneumoniae_NP CiaRH_NP two-component_JJ system_NN ,_, which_WDT is_VBZ closely_RB related_VBN to_TO LisRK_NP and_CC which_WDT plays_VBZ a_DT role_NN in_IN cefotaxime_NN resistance_NN as_IN well_RB as_RB in_IN other_JJ phenotypes_NNS attributable_JJ to_TO the_DT cell_NN envelope_NN ,_, also_RB controls_VBZ levels_NNS of_IN undecaprenol_NN (_( bactoprenol_NN )_) ,_, a_DT component_NN of_IN lipid_NN II_NP (_( N-acetylglucosamine-beta-1,4-MurNAc-pentapeptide-pyrophosphoryl-undecaprenol_NP )_) as_RB well_RB as_IN monitoring_VBG the_DT integrity_NN of_IN the_DT cell_NN wall_NN in_IN general_NN ._SENT This_DT is_VBZ especially_RB relevant_JJ as_IN lipid_NN II_NP serves_VBZ as_IN the_DT docking_VBG molecule_NN for_IN nisin_NN binding_VBG prior_RB to_TO pore_VB formation_NN and_CC is_VBZ the_DT target_NN for_IN its_PP$ secondary_JJ mode_NN of_IN action_NN ,_, inhibition_NN of_IN cell_NN wall_NN synthesis_NN ._SENT Though_IN the_DT nisin_NN resistance_NN of_IN CiaRH_NP mutants_NNS has_VBZ not_RB been_VBN reported_VBN ,_, it_PP is_VBZ tempting_JJ to_TO suggest_VB ,_, on_IN the_DT basis_NN of_IN the_DT involvement_NN of_IN lipid_NN II_NP ,_, that_IN their_PP$ resistance_NN would_MD be_VB modified_VBN and_CC thus_RB that_DT further_JJR examination_NN of_IN this_DT pathway_NN in_IN the_DT appropriate_JJ mutants_NNS may_MD reveal_VB the_DT mechanism_NN responsible_JJ for_IN the_DT correlation_NN between_IN nisin_NN resistance_NN and_CC cephalosporin_NN sensitivity_NN ._SENT Implementation_NN of_IN the_DT NICE_NP system_NN in_IN L._NP monocytogenes_NNS LO28DeltalisK_NP ._SENT |_SYM To_TO confirm_VB that_IN the_DT observed_JJ phenotypic_JJ and_CC transcriptional_JJ changes_NNS associated_VBN with_IN the_DT deletion_NN in_IN lisK_NN were_VBD linked_VBN to_TO its_PP$ interaction_NN with_IN the_DT cognate_JJ LisR_NP regulator_NN (_( and_CC not_RB due_JJ to_TO cross_VB talk_NN or_CC a_DT secondary_JJ undetected_JJ mutation_NN in_IN LO28DeltalisK_NP )_) ,_, we_PP designed_VBD a_DT strategy_NN to_TO overexpress_VB LisR_NP in_IN the_DT LO28DeltalisK_NP background_NN ._SENT The_DT rationale_NN for_IN this_DT approach_NN stems_VBZ from_IN the_DT observation_NN that_IN in_IN certain_JJ circumstances_NNS overexpression_NN of_IN a_DT response_NN regulator_NN alone_RB may_MD mimic_VB activation_NN thereof_RB ._SENT This_DT phenomenon_NN may_MD be_VB explained_VBN by_IN the_DT observation_NN that_IN a_DT number_NN of_IN response_NN regulators_NNS are_VBP capable_JJ of_IN binding_VBG their_PP$ target_NN DNA_NN when_WRB nonphosphorylated_JJ ,_, though_RB less_RBR efficiently_RB than_IN when_WRB phosphorylated_JJ ._SENT It_PP may_MD also_RB be_VB possible_JJ that_IN the_DT high_JJ stoichiometry_NN of_IN LisR_NP allows_VBZ some_DT level_NN of_IN phosphorylation_NN as_IN a_DT result_NN of_IN either_DT cross_NN talk_NN or_CC the_DT possible_JJ contribution_NN of_IN another_DT histidine_NN kinase_NN that_WDT specifically_RB interacts_VBZ with_IN LisR_NP (_( the_DT existence_NN of_IN which_WDT has_VBZ not_RB been_VBN ruled_VBN out_RB )_) ._SENT Therefore_RB ,_, a_DT system_NN to_TO allow_VB overexpression_NN of_IN LisR_NP was_VBD necessary_JJ to_TO investigate_VB whether_IN excess_JJ LisR_NP could_MD complement_VB the_DT absence_NN of_IN LisK_NP ._SENT In_IN addition_NN to_TO the_DT need_NN for_IN a_DT very_RB strong_JJ promoter_NN it_PP was_VBD desirable_JJ that_IN the_DT system_NN also_RB be_VB inducible_JJ ,_, in_IN the_DT hope_NN that_IN it_PP might_MD ultimately_RB facilitate_VB the_DT identification_NN of_IN additional_JJ promoters_NNS controlled_VBN by_IN LisRK_NP by_IN using_VBG a_DT strategy_NN analogous_JJ to_TO that_DT used_VBN by_IN Soncini_NP et_FW al._FW to_TO identify_VB PhoPQ-regulated_JJ genes_NNS in_IN Salmonella_NP enterica_NP serovar_NP Typhimurium_NP ._SENT Due_JJ to_TO the_DT paucity_NN of_IN controlled_VBN expression_NN systems_NNS in_IN Listeria_NN and_CC the_DT extent_NN to_TO which_WDT it_PP can_MD overexpress_VB proteins_NNS ,_, the_DT lactococcal_JJ NICE_NP system_NN was_VBD employed_VBN ._SENT The_DT NICE_NP system_NN has_VBZ the_DT advantage_NN of_IN being_VBG extremely_RB responsive_JJ to_TO an_DT external_JJ stimulus_NN (_( nisin_NN )_) and_CC has_VBZ been_VBN successfully_RB used_VBN in_IN a_DT number_NN of_IN other_JJ gram-positive_JJ genera_NNS ,_, including_VBG Leuconostoc_NP and_CC Lactobacillus_NP and_CC Streptococcus_NP ,_, Enterococcus_NP ,_, and_CC Bacillus_NN ._SENT It_PP depends_VBZ on_IN the_DT presence_NN of_IN a_DT two-component_JJ signal_NN transduction_NN system_NN (_( NisRK_NP )_) which_WDT senses_VBZ nisin_NN in_IN the_DT external_JJ environment_NN and_CC stimulates_VBZ transcription_NN from_IN the_DT Pnis_NP promoter_NN ._SENT Although_IN nisin_NN is_VBZ both_CC the_DT induction_NN factor_NN for_IN the_DT NICE_NP system_NN and_CC one_CD of_IN the_DT inhibitors_NNS under_IN investigation_NN in_IN this_DT study_NN ,_, because_IN of_IN the_DT relative_JJ differences_NNS in_IN concentration_NN required_VBN for_IN induction_NN and_CC for_IN inhibition_NN ,_, we_PP were_VBD able_JJ to_TO utilize_VB nisin_NN as_IN both_DT inducer_NN and_CC challenge_NN to_TO determine_VB whether_IN overexpression_NN of_IN LisR_NP can_MD overcome_VB the_DT DeltalisK_NP lesion_NN ._SENT Original_JJ applications_NNS of_IN the_DT NICE_NP system_NN used_VBD two_CD plasmids_NNS ,_, one_CD with_IN a_DT nisA_NN promoter_NN and_CC the_DT relevant_JJ gene_NN to_TO be_VB overexpressed_VBN and_CC the_DT second_NN on_IN which_WDT the_DT nisRK_JJ regulatory_JJ genes_NNS were_VBD located_VBN in_IN trans_NNS ._SENT More-recent_JJ innovations_NNS involve_VBP either_RB placing_VBG the_DT nisRK_NN genes_NNS on_IN the_DT host_NN chromosome_NN ,_, allowing_VBG the_DT subsequent_JJ use_NN of_IN a_DT one-plasmid_JJ system_NN ,_, or_CC placing_VBG both_DT nisRK_NN and_CC the_DT nisA_NN promoter_NN on_IN a_DT single_JJ plasmid_NN ._SENT We_PP used_VBD the_DT former_JJ approach_NN and_CC introduced_VBD the_DT nisRK_NN genes_NNS onto_IN the_DT listerial_JJ chromosome_NN ,_, replacing_VBG the_DT hemolysin_NN (_( hly_NN )_) gene_NN and_CC placing_VBG nisRK_NN under_IN the_DT control_NN of_IN the_DT hly_JJ promoter_NN ._SENT This_DT replacement_NN did_VBD not_RB impact_NN on_IN the_DT level_NN of_IN resistance_NN of_IN the_DT strain_NN ._SENT This_DT particular_JJ gene_NN replacement_NN strategy_NN was_VBD chosen_VBN because_IN transcription_NN of_IN hly_NNS in_IN strain_NN LO28_NP in_IN vitro_NP is_VBZ constitutively_RB high_JJ but_CC can_MD be_VB further_RBR increased_VBN (_( by_IN the_DT addition_NN of_IN charcoal_NN to_TO the_DT culture_NN medium_NN )_) or_CC decreased_VBD (_( by_IN a_DT reduction_NN in_IN growth_NN temperature_NN from_IN 37_CD to_TO 20C_NP )_) if_IN required_VBN ._SENT Second_RB ,_, this_DT has_VBZ the_DT advantage_NN of_IN creating_VBG a_DT much_RB less_RBR virulent_JJ host_NN with_IN which_WDT to_TO perform_VB physiological_JJ assays_NNS ._SENT The_DT strain_NN resulting_VBG from_IN this_DT procedure_NN ,_, the_DT construction_NN of_IN which_WDT is_VBZ described_VBN in_IN Materials_NPS and_CC Methods_NP ,_, was_VBD designated_VBN LO28DeltalisK-NICE_NP ._SENT To_TO overexpress_VB LisR_NP ,_, the_DT corresponding_JJ gene_NN was_VBD cloned_VBN into_IN pNZ8048_NN behind_IN the_DT Pnis_NP promoter_NN ._SENT The_DT resulting_VBG plasmid_NN ,_, designated_VBN pNZ8048-lisR_NN ,_, was_VBD introduced_VBN into_IN LO28DeltalisK-NICE_NP ._SENT Plasmid_NP pNZ8048_NN lacking_VBG an_DT insert_NN was_VBD also_RB introduced_VBN into_IN the_DT same_JJ background_NN for_IN use_NN as_IN a_DT negative_JJ control_NN in_IN subsequent_JJ experiments_NNS ._SENT To_TO confirm_VB that_DT nisin_NN induced_VBD overexpression_NN of_IN a_DT lisR_NN transcript_NN ,_, an_DT RT-PCR_NP comparing_VBG the_DT relative_JJ quantities_NNS of_IN lisR_NN mRNA_NN in_IN the_DT two_CD backgrounds_NNS was_VBD performed_VBN ._SENT After_IN 15_CD cycles_NNS it_PP was_VBD apparent_JJ that_IN the_DT levels_NNS of_IN lisR_NN mRNA_NNS being_VBG produced_VBN ,_, following_VBG induction_NN by_IN nisin_NN (_( 45_CD mug/ml_NN )_) ,_, were_VBD much_RB greater_JJR when_WRB pNZ8048-lisR_NN ,_, rather_RB than_IN pNZ8048_NN ,_, was_VBD present_JJ ._SENT Complementation_NN of_IN the_DT DeltalisK_NP phenotype_NN by_IN overexpression_NN of_IN lisR_NN ._SENT |_SYM To_TO determine_VB whether_IN overexpressing_NN lisR_NN reversed_VBD the_DT enhanced_JJ nisin_NN resistance_NN displayed_VBN by_IN LO28DeltalisK_NP ,_, we_PP compared_VBD the_DT growth_NN of_IN LO28DeltalisK-NICE_NP containing_VBG pNZ8048-lisR_NN to_TO that_DT when_WRB it_PP contained_VBD pNZ8048_NN ._SENT The_DT level_NN of_IN nisin_NN required_VBN to_TO affect_VB the_DT growth_NN of_IN the_DT strains_NNS (_( greater_JJR than_IN 100_CD mug/ml_NN )_) was_VBD in_IN excess_NN of_IN that_DT required_VBN to_TO induce_VB the_DT NICE_NP system_NN maximally_RB (_( 45_CD mug/ml_NN )_) ,_, thus_RB allowing_VBG the_DT induction_NN of_IN lisR_NN and_CC the_DT examination_NN of_IN the_DT growth_NN kinetics_NN under_IN nisin_NN inhibition_NN ._SENT The_DT results_NNS confirmed_VBD that_DT induction_NN of_IN lisR_NN results_NNS in_IN a_DT reversion_NN to_TO nisin_NN sensitivity_NN ,_, overcoming_VBG the_DT DeltalisK_NP mutation_NN ._SENT As_RB in_IN the_DT parental_JJ strain_NN ,_, this_DT sensitivity_NN manifests_VBZ itself_PP as_IN an_DT increased_VBN lag_NN period_NN relative_JJ to_TO that_DT of_IN LO28DeltalisK-NICE(pNZ8048)_NP ,_, which_WDT is_VBZ 6_CD h_NN in_IN the_DT presence_NN of_IN 300_CD mug_NN of_IN nisin/ml_NN ._SENT Overexpression_NN of_IN LisR_NP by_IN nisin_NN was_VBD also_RB found_VBN to_TO result_VB in_IN a_DT reversion_NN to_TO wild-type_NN levels_NNS of_IN ethanol_NN sensitivity_NN (_( data_NNS not_RB shown_VBN )_) though_IN a_DT reversion_NN to_TO cephalosporin_NN resistance_NN was_VBD not_RB apparent_JJ ._SENT For_IN fear_NN that_IN the_DT use_NN of_IN nisin_NN was_VBD interfering_VBG with_IN the_DT ability_NN of_IN the_DT NICE_NP system_NN to_TO complement_VB cephalosporin_NN sensitivity_NN ,_, an_DT alternative_JJ overexpression_NN vector_NN ,_, pNZ44_NN ,_, was_VBD used_VBN ._SENT This_DT vector_NN is_VBZ a_DT derivative_NN of_IN pNZ8048_NN in_IN which_WDT a_DT constitutive_JJ P44_NP promoter_NN replaces_VBZ the_DT inducible_JJ Pnis_NP ._SENT It_PP was_VBD found_VBN that_IN LO28DeltalisK_NN containing_VBG pNZ44-lisR_NN exhibited_VBD a_DT reversion_NN to_TO cephalosporin_NN resistance_NN ,_, though_IN the_DT degree_NN of_IN reversion_NN varied_VBD depending_VBG on_IN the_DT antibiotic_NN used_VBD ._SENT This_DT system_NN was_VBD also_RB used_VBN to_TO determine_VB if_IN the_DT levels_NNS of_IN the_DT three_CD genes_NNS associated_VBN with_IN nisin_NN resistance_NN increased_VBN in_IN response_NN to_TO LisR_NP overexpression_NN ._SENT It_PP was_VBD found_VBN that_IN ,_, while_IN increases_NNS in_IN the_DT levels_NNS of_IN transcript_NN corresponding_JJ to_TO lmo2487_JJ (_( gene_NN C_NP )_) and_CC ,_, to_TO a_DT much_RB lesser_JJR extent_NN ,_, lmo2229_NP (_( PBP_NP )_) were_VBD observed_VBN ,_, no_DT change_NN in_IN the_DT level_NN of_IN lmo1021_JJ (_( histidine_NN kinase_NN )_) was_VBD detected_VBN ._SENT The_DT variation_NN in_IN the_DT extent_NN to_TO which_WDT complementation_NN of_IN the_DT cephalosporin_NN sensitivity_NN phenotype_NN occurred_VBD may_MD reflect_VB either_RB the_DT involvement_NN of_IN an_DT alternate_JJ response_NN regulator_NN that_WDT interacts_VBZ with_IN LisK_NP or_CC ,_, more_RBR likely_JJ ,_, variations_NNS in_IN the_DT affinity_NN of_IN LisR_NP for_IN the_DT three_CD promoters_NNS ,_, analogous_JJ to_TO the_DT differential_JJ expression_NN of_IN genes_NNS within_IN the_DT regulon_NN of_IN the_DT closely_RB related_VBN CsrR_NP response_NN regulator_NN in_IN Streptococcus_NP pyogenes_NNS ._SENT As_RB well_RB as_IN examining_VBG the_DT regulation_NN and_CC function_NN of_IN the_DT PBPs_NP ,_, histidine_NN kinase_NN ,_, and_CC gene_NN C_NN we_PP are_VBP currently_RB attempting_VBG to_TO identify_VB both_DT additional_JJ genes_NNS under_IN the_DT control_NN of_IN LisR_NP (_( using_VBG the_DT inducible_JJ overexpression_NN strategy_NN alluded_VBD to_TO previously_RB )_) and_CC the_DT stimulus_NN which_WDT triggers_VBZ LisK_NP ,_, so_RB that_IN we_PP can_MD gain_VB a_DT more_RBR precise_JJ understanding_NN of_IN the_DT molecular_JJ mechanisms_NNS underlying_VBG this_DT phenomenon_NN ._SENT In_IN conclusion_NN ,_, we_PP have_VBP shown_VBN that_IN the_DT LisRK_NP two-component_JJ signal_NN transduction_NN system_NN ,_, in_IN addition_NN to_TO playing_VBG a_DT role_NN in_IN the_DT response_NN of_IN bacteria_NNS to_TO acid_NN ,_, ethanol_NN ,_, hydrogen_NN peroxide_NN ,_, and_CC in_IN vivo_JJ stresses_NNS ,_, has_VBZ a_DT major_JJ role_NN in_IN the_DT growth_NN of_IN this_DT potentially_RB lethal_JJ food_NN pathogen_NN in_IN the_DT presence_NN of_IN lantibiotic_JJ bacteriocin_NN and_CC in_IN determining_VBG the_DT sensitivity_NN to_TO antibiotics_NNS within_IN the_DT cephalosporin_NN family_NN ._SENT A_DT link_NN between_IN nisin_NN resistance_NN and_CC cephalosporin_NN sensitivity_NN ,_, previously_RB observed_VBN by_IN Gravesen_NP et_FW al._FW ,_, in_IN spontaneous_JJ mutants_NNS has_VBZ been_VBN confirmed_VBN ,_, three_CD genes_NNS associated_VBN with_IN this_DT phenotype_NN have_VBP been_VBN shown_VBN to_TO controlled_VBN through_IN LisK_NP ,_, and_CC it_PP has_VBZ been_VBN shown_VBN that_IN complete_JJ or_CC partial_JJ complementation_NN of_IN the_DT phenotypes_NNS displayed_VBN by_IN LO28DeltalisK_NP can_MD be_VB reversed_VBN by_IN overexpressing_VBG lisR_NN ._SENT Finally_RB ,_, in_IN the_DT process_NN of_IN determining_VBG the_DT role_NN of_IN LisRK_NP in_IN nisin_NN resistance_NN ,_, we_PP have_VBP also_RB confirmed_VBN that_IN the_DT NICE_NP system_NN functions_NNS in_IN L._NP monocytogenes_NNS ._SENT The_DT importance_NN of_IN this_DT finding_NN stems_VBZ from_IN the_DT lack_NN of_IN inducible_JJ gene_NN expression_NN systems_NNS for_IN Listeria_NN and_CC the_DT adaptability_NN of_IN the_DT NICE_NP system_NN ,_, which_WDT permits_VBZ precise_JJ regulation_NN of_IN expression_NN levels_NNS and_CC which_WDT can_MD facilitate_VB the_DT production_NN of_IN very_RB high_JJ levels_NNS of_IN recombinant_JJ proteins_NNS ._SENT The_DT relatively_RB high_JJ nisin_NN resistance_NN of_IN strain_NN LO28_NP makes_VBZ it_PP especially_RB suitable_JJ for_IN use_NN with_IN this_DT system_NN to_TO facilitate_VB the_DT identification_NN of_IN the_DT LisRK_NP regulon_NN and_CC potentially_RB genes_NNS controlled_VBN by_IN other_JJ transcriptional_JJ regulators_NNS in_IN Listeria_NN ._SENT It_PP should_MD also_RB prove_VB a_DT useful_JJ tool_NN for_IN others_NNS interested_JJ in_IN expressing_VBG foreign_JJ proteins_NNS in_IN L._NP monocytogenes_NNS ._SENT FIG._NN 1_CD ._SENT |_SYM Growth_NN of_IN LO28DeltalisK_NP in_IN the_DT presence_NN of_IN antimicrobial_JJ agents_NNS ._SENT Growth_NN of_IN LO28DeltalisK_NP in_IN the_DT presence_NN of_IN antimicrobial_JJ agents_NNS ._SENT Shown_VBN is_VBZ growth_NN of_IN LO28_NP (_( circles_NNS )_) and_CC LO28DeltalisK_NP (_( squares_NNS )_) in_IN TSB-YE_NP with_IN 0_CD (_( A_NP )_) ,_, 50_NP (_( B_NP )_) ,_, 100_NP (_( C_NP )_) ,_, 200_NP (_( D_NP )_) ,_, and_CC 300_CD (_( E_NN )_) mug_NN of_IN nisin_NN powder/ml_NN ._SENT Growth_NN was_VBD determined_VBN by_IN using_VBG a_DT Spectra_NP Max_NP 340_CD spectrophotometer_NN (_( Molecular_NP Devices_NPS )_) over_IN a_DT 20-h_JJ period_NN ._SENT Error_NN bars_NNS ,_, standard_JJ deviations_NNS from_IN the_DT means_NNS of_IN quadruplicate_JJ experiments_NNS ._SENT FIG._NN 2_CD ._SENT |_SYM (_( A_NP and_CC B_NP )_) RT-PCRs_NN to_TO compare_VB levels_NNS of_IN transcripts_NNS for_IN genes_NNS whose_WP$ products_NNS show_VBP homology_NN to_TO histidine_NN kinase_NN (_( HK_NP )_) ,_, a_DT protein_NN of_IN unknown_JJ function_NN (_( gene_NN C_NP )_) ,_, and_CC a_DT PBP_NN in_IN strains_NNS LO28_NP (_( L_NP )_) and_CC LO28DeltalisK_NP (_( DeltaK_NP )_) (_( A_NP )_) and_CC LO28DeltalisK(pNZ44lisR)_NP (_( +R_NN )_) and_CC LO28DeltalisK(pNZ44)_NP (_( -R_NP )_) (_( B_NP )_) ._SENT (_( A_NP and_CC B_NP )_) RT-PCRs_NN to_TO compare_VB levels_NNS of_IN transcripts_NNS for_IN genes_NNS whose_WP$ products_NNS show_VBP homology_NN to_TO histidine_NN kinase_NN (_( HK_NP )_) ,_, a_DT protein_NN of_IN unknown_JJ function_NN (_( gene_NN C_NP )_) ,_, and_CC a_DT PBP_NN in_IN strains_NNS LO28_NP (_( L_NP )_) and_CC LO28DeltalisK_NP (_( DeltaK_NP )_) (_( A_NP )_) and_CC LO28DeltalisK(pNZ44lisR)_NP (_( +R_NN )_) and_CC LO28DeltalisK(pNZ44)_NP (_( -R_NP )_) (_( B_NP )_) ._SENT (_( C_NP )_) Confirmation_NN of_IN the_DT overexpression_NN of_IN lisR_NN by_IN RT-PCR_NP using_VBG lisR-specific_JJ PCR_NP primers_NNS to_TO amplify_VB cDNA_NN templates_NNS of_IN equal_JJ concentrations_NNS generated_VBN from_IN LO28DeltalisKNICE(pNZ8048)_NP or_CC LO28DeltalisKNICE(pNZ8048-lisR)_NP RNA_NP following_VBG nisin_NN induction_NN ._SENT In_IN all_DT cases_NNS control_VBP PCR_NP primers_NNS were_VBD used_VBN to_TO ensure_VB the_DT complete_JJ removal_NN of_IN DNA_NP from_IN RNA_NP preparations_NNS prior_RB to_TO reverse_VB transcription_NN and_CC to_TO ensure_VB that_IN levels_NNS of_IN cDNA_NN for_IN samples_NNS that_WDT were_VBD to_TO be_VB compared_VBN were_VBD equal_JJ ._SENT FIG._NN 3_CD ._SENT |_SYM Complementation_NN of_IN the_DT nisin_NN resistance_NN phenotype_NN of_IN LO28DeltalisK_NP by_IN using_VBG the_DT NICE_NP system_NN ._SENT Complementation_NN of_IN the_DT nisin_NN resistance_NN phenotype_NN of_IN LO28DeltalisK_NP by_IN using_VBG the_DT NICE_NP system_NN ._SENT Growth_NN of_IN LO28DeltalisKNICE(pNZ8048)_NP (_( squares_NNS )_) and_CC LO28DeltalisKNICE(pNZ8048-lisR)_NP (_( circles_NNS )_) in_IN TSB-YE_NP with_IN 0_CD (_( A_NP )_) ,_, 50_NP (_( B_NP )_) ,_, 100_NP (_( C_NP )_) ,_, 200_NP (_( D_NP )_) ,_, and_CC 300_CD (_( E_NN )_) mug_NN of_IN nisin_NN powder/ml_NN ._SENT Growth_NN was_VBD determined_VBN by_IN using_VBG a_DT Spectra_NP Max_NP 340_CD spectrophotometer_NN (_( Molecular_NP Devices_NPS )_) over_IN a_DT 20-h_JJ period_NN ._SENT Error_NN bars_NNS ,_, standard_JJ deviations_NNS from_IN the_DT means_NNS of_IN quadruplicate_JJ experiments_NNS ._SENT TABLE_NN 2_CD |_SYM Cephalosporin_NP resistance_NN of_IN LO28_NP and_CC LO28DeltalisK_NP 